GenSight Biologics
SIGHT.PA
#10723
Rank
C$28.94 M
Marketcap
C$0.12
Share price
-1.45%
Change (1 day)
-30.26%
Change (1 year)

Earnings for GenSight Biologics (SIGHT.PA)

Earnings in 2025: -C$20.29 Million

According to GenSight Biologics's latest financial reports the company's current earnings are C$0 Million. In 2025 the company made an earning of -C$20.29 Million, an increase over its 2024 earnings that were of -C$20.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for GenSight Biologics from 2013 to 2025

Annual earnings

Year Earnings Change
2025-C$20.29 Million-2.77%
2024-C$20.87 Million-49.81%
2023-C$41.57 Million-2.16%
2022-C$42.49 Million-8.58%
2021-C$46.48 Million-22.54%
2020-C$60 Million21.01%
2019-C$49.59 Million-9.66%
2018-C$54.88 Million32.28%
2017-C$41.49 Million24.57%
2016-C$33.31 Million55.57%
2015-C$21.41 Million84%
2014-C$11.64 Million112.64%
2013-C$5.48 Million